Training Example: YESCARTA (Kite/Gilead) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

YESCARTA (Kite/Gilead)

(https://yescarta.com) 📸 Data Snapshot: June 20, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults (https://yescarta.com)
Title

YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults

Meta

Learn about YESCARTA® (axicabtagene ciloleucel) a CAR T-cell therapy for certain types of non-Hodgkin lymphoma in adults. See Important Safety Information & Warnings.

H1 YESCARTA® is a CAR T-cell therapy made from your own immune system.
H2 Why YESCARTA?
H2 Starting Points
H3 It has helped many patients reach a complete and lasting remission.*
H3 Treatment center locator tool
H4 You are now leaving YESCARTA.com
H4 You are now leaving YESCARTA.com
NAV_HEADER_REPEATED_BODY Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site (https://yescarta.com/managing-side-effects/)
Title

Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site

Meta

Learn about the possible side effects of YESCARTA® (axicabtagene ciloleucel) and how treatment teams, caregivers, and patients manage these side effects. See Important Safety Information & Warnings.

H1 Managing side effects
H2 What are the possible side effects of YESCARTA?
H2 How will the treatment team manage side effects and keep me safe?
H2 What is my role in managing side effects?
H2 During YESCARTA infusion and close daily monitoring
H2 During continued monitoring
H2 During recovery at home
H2 Patient and caregiver perspectives
H3 Certified treatment centers
H3 Treatment center locator tool
H3 Cytokine Release Syndrome (CRS)
H3 Neurotoxicity
H3 Some health checks your treatment team might do:
H3 Some simple tasks your treatment team might ask you to do:
H4 What you can do
H4 What you can do
H4 What you can do
H4 You are now leaving YESCARTA.com
H4 You are now leaving YESCARTA.com
NAV_HEADER_REPEATED_BODY Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site (https://yescarta.com/support-and-resources/)
Title

Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site

Meta

Learn about the types of support and resources that may be helpful throughout treatment and who to ask for help. See Important Safety information & Warnings.

H1 Support and resources
H2 Is YESCARTA covered by insurance?
H2 Who can help me find information on resources and support?
H2 Where else can I find support?
H2 YESCARTA video library
H2 Downloadable resources
H3 Treatment center locator tool
H3 Out-of-pocket costs
H3 How do I find out if my insurance covers YESCARTA?
H3 Financial support
H3 Travel and lodging support
H3 Day-to-day support
H3 Mental health, emotional support, and peer groups
H3 Physical wellness support
H3 Educational support
H4 You are now leaving YESCARTA.com
H4 You are now leaving YESCARTA.com
H4 American Cancer Society
H4 Bone Marrow & Cancer Foundation
H4 BMT InfoNet
H4 CancerCare
H4 Cancer Support Community
H4 Family Reach Foundation
H4 Leukemia & Lymphoma Society
H4 Lymphoma Research Foundation
H4 National Cancer Institute
H4 Patient Advocate Foundation
H4 Air Care Alliance
H4 American Cancer Society
H4 BMT InfoNet
H4 Cancer Support Community
H4 Corporate Angel Network
H4 Footprints in the Sky
H4 Grace On Wings
H4 Healthcare Hospitality Network
H4 Joe’s House
H4 Leukemia & Lymphoma Society
H4 Mercy Medical Angels
H4 American Cancer Society
H4 CancerCare
H4 Cancer Support Community
H4 Leukemia & Lymphoma Society
H4 BMT InfoNet
H4 Cancer.net
H4 CancerCare
H4 Cancer Support Community
H4 Leukemia & Lymphoma Society
H4 Lymphoma Research Foundation
H4 Patient Empowerment Network
H4 American Cancer Society
H4 American Institute for Cancer Research
H4 CancerCare
H4 Cancer Support Community
H4 Leukemia & Lymphoma Society
H4 Lymphoma Research Foundation
H4 American Cancer Society
H4 BMT InfoNet
H4 CancerCare
H4 Cancer Support Community
H4 Leukemia & Lymphoma Society
H4 Lymphoma Research Foundation
H4 National Cancer Institute
H4 Patient Empowerment Network
NAV_HEADER_REPEATED_BODY_FOOTER YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site (https://yescarta.com/clinical-trial-results/)
Title

YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site

Meta

Learn about how patients responded to YESCARTA® (axicabtagene ciloleucel) in clinical trials. See Important Safety Information & Warnings.

H1 YESCARTA results
H2 How has YESCARTA been studied?
H2 For LBCL patients whose cancer returned after their first treatment: YESCARTA showed improved results compared to standard therapy.
H2 What are the results from the other YESCARTA clinical trials?
H2 Where can I learn more about the possible side effects of YESCARTA?
H3 Treatment center locator tool
H3 Standard therapy
H3 Trial in LBCL (2nd line)
H3 Trial in LBCL (3rd line)
H3 Overall survival
H3 Event-free survival
H3 Trial in FL (3rd line)
H4 You are now leaving YESCARTA.com
H4 You are now leaving YESCARTA.com
H4 People in the trial
H4 People in the trial
H4 People in the trial
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://yescarta.com) YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults
[H1] YESCARTA® is a CAR T-cell therapy made from your own immune system.
[H3] It has helped many patients reach a complete and lasting remission.*
*Complete remission (also known as complete response) is the disappearance of all signs of cancer. It does not always mean that the cancer has been cured.

[IMG: What to know about CAR T patient video thumbnail.]

Video: What to know about CAR T

This testimonial is representative of patients' and caregivers' own experiences. Individual treatment results and experience may vary.
YESCARTA may be an option for some patients with Large B-Cell Lymphoma (LBCL) or Follicular Lymphoma (FL).

[H2] Why YESCARTA?
Over 25,000
patients have been treated with YESCARTA since it was approved in
2017.1 While there are multiple steps in the treatment process,
YESCARTA is a one-time infusion.2
1As
of July 2025, this number includes global internal Kite commercial
and clinical trial data.
2Not including pre-treatment or low-dose
chemotherapy.

[IMG: Purple circle icon with 2x text.]
2nd line LBCL
Two years after
treatment, patients who received YESCARTA were more than twice as likely
to stay event free compared to patients who received standard therapy.
Event-free
survival is the length of time after treatment that patients go without
having their cancer come back, get worse, or experience any other
complications or worsening of symptoms.
Learn more

[IMG: First and only approved CAR T treatment in adult 2L LBCL]

[IMG: 7 in 10 patients circles icon.]

Ask your doctor if
YESCARTA is an option for you.

[H2] Starting Points
Explore information that may be helpful to you at different stages of treatment:

Who YESCARTA is for and how it works
chevron_right

Important considerations for YESCARTA
chevron_right

How YESCARTA worked for other patients
chevron_right

Side effects and how they are managed
chevron_right

Information about insurance coverage
chevron_right

Treatment steps and preparation guide
chevron_right

YESCARTA infusion and close daily monitoring
chevron_right

Continued monitoring for side effects
chevron_right

Get help finding information on YESCARTA, resources, and support
chevron_right

Caregiver role and support
chevron_right

Managing side effects at home
chevron_right

Support and resources along the way
chevron_right

Caregiver role and support
chevron_right

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

[H4] You are now leaving YESCARTA.com

The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving YESCARTA.com

You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3] Treatment center locator tool
There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA.
You can use the locator tool to find and learn about nearby treatment centers and their teams.
Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more.

Traveling From

Typical driving times around your location

1 hour
2 hours

Copy link
Print information

Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options.

Find a treatment center near you that offers YESCARTA:
Find a treatment center near you that offers YESCARTA:

Find a treatment center

Approved Uses

YESCARTA is a prescription medicine used to treat two types of non-Hodgkin
lymphoma ...

Important Safety Information

What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that
are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma:

large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.

follicular lymphoma when at least two kinds of treatment have failed to control your cancer.

YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA. Your healthcare provider may give you other medicines to treat your side
effects.

Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had:
Neurologic problems (such as seizures, stroke, or memory loss)
Lung or breathing problems
Heart problems
Liver problems
Kidney problems
A recent or active infection
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive YESCARTA?
Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
Your blood cells will be sent to a manufacturing center to make your YESCARTA.
Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body.
When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
You will be monitored daily for at least 7 days after the infusion.
You should plan to stay close to a healthcare facility for at least 2 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur.
You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon
as possible to reschedule.

What should I avoid after receiving YESCARTA?

Avoid driving for at least 2 weeks after you get YESCARTA.
Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of YESCARTA?
The most common side effects of YESCARTA include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
YESCARTA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.

These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

Please see Important Facts, including IMPORTANT
WARNINGS before you receive YESCARTA.

You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom
of the screen.
9938 chars
SUB-PAGE (https://yescarta.com/managing-side-effects/) Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site
[H1]
Managing side effects

[IMG: medical-professional-helping-patient-manage-side-effects]

On this page
What are the possible side effects of YESCARTA?
How will the treatment team manage side effects and keep me safe?
What is my role in managing side effects?
During YESCARTA infusion and close monitoring
During continued monitoring
During recovery at home
Patient and caregiver perspectives

[H2] What are the possible side effects of YESCARTA?

Because YESCARTA is a treatment that works on your immune system, there is a risk that your immune system may become overactive and affect the rest of your body in unwanted ways. You can learn about the
possible side effects of YESCARTA by reading the Important Safety Information.

Two side effects that many patients have experienced are
Cytokine Release Syndrome (CRS)?
and Neurotoxicity?:

CRS and Neurotoxicity can become life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA. Your healthcare provider may
give you other medicines to treat your side effects.

The most common side effects of YESCARTA include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
YESCARTA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.

These are not all the possible side effects of YESCARTA. It’s important to talk to your treatment team about how you are feeling, and let them know if you notice any symptoms. Each
person's experience and potential side effects will be different.

[H2] How will the treatment team manage side effects and keep me safe?
Your safety and care are top priority. There will be multiple safety measures in place throughout your YESCARTA treatment experience:

[H2] What is my role in managing side effects?

Both patients and caregivers play an important role during CAR T treatment. See below for what you can do and how your responsibilities may shift throughout treatment.
Remember that you can always ask your treatment team if you have questions about side effects and how to look for them.

[H2] During YESCARTA infusion and close daily monitoring

To help prepare for your CAR T-cell infusion, your treatment team may give you premedications.
You will be monitored daily for at least 1 week after infusion in case serious side effects happen. During this time, you will be under the care of your treatment team. Serious side effects are most likely in the first few weeks after infusion.

Your treatment team is well equipped to manage and treat side effects. They will regularly complete
health checks? and ask you to do
some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications.

[IMG: A patient with the oncologist and caregiver during YESCARTA® (axicabtagene ciloleucel) infusion at the certified treatment center]

Your treatment team is well equipped to manage and treat side effects. They will regularly complete
health checks? and ask you to do
some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications.

[H4] What you can do

Proactively tell the treatment team if you notice any changes in how you're feeling. Caregivers may be the first to notice side effects, as some symptoms can be difficult for patients to recognize by
themselves.
The treatment team can also answer any questions you may have about side effects and how to look for them.

Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page.

“Every day while I was in the hospital, each shift of nurses would have me write my name on a piece of paper, ask me what day it was, and ask me to identify five different objects in my room.”

MargaretYESCARTA Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: Margaret YESCARTA® (axicabtagene ciloleucel) patient ambassador looking out the window.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[H2] During continued monitoring

You should plan to stay close to a healthcare facility for at least 2 weeks after infusion, so you can get help quickly if any side effects occur. Your treatment team will let you know where this continued monitoring will take place. Avoid driving for at least 2 weeks after infusion.

[IMG: A caregiver taking a patient]

[H4] What you can do

Follow your treatment team’s instructions for monitoring for signs and symptoms of side effects. You will be responsible for monitoring side effects once you’ve left the center.
Notify your treatment team immediately if you notice any changes. Receiving medical attention right away may keep side effects from becoming more serious.
It is important to tell any healthcare providers you visit that you received YESCARTA, and have your treatment team’s contact information on hand.

Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page.

“I was hyper-aware of every little change my body was going through, and it was a little overwhelming! My mom and I had a detailed schedule for when to take meds, blood pressure, and temperature. We had alarms on our phones and a checklist to make sure we didn't miss anything.”

LayraYESCARTA Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: Laura comforting Layra, a YESCARTA® (axicabtagene ciloleucel) patient ambassador.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[H2] During recovery at home

When the treatment team thinks you are ready—at least 2 weeks after infusion—you'll no longer be required to stay near a healthcare facility. If you had to travel for treatment, this means you can now return home. You may also start returning to your local oncologist for follow-up appointments.

[IMG: A caregiver continuing to take care of a recovering patient at home.]

[H4] What you can do

Continue to look out for side effects and talk to your healthcare teams about how you are feeling. Make sure to attend follow-up appointments. If you miss an appointment, it’s important to reschedule as soon as possible.
You should continue to tell any healthcare providers you visit that you received YESCARTA.

Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page.

“When we were in the hospital, if something went wrong, I could just stick my head out the door and a whole medical team would be there. At home, we don’t have that. But I had the numbers for emergency help and knowing that was available to me made me feel better.”

SkipYESCARTA Caregiver

This testimonial is representative of the caregiver’s own experience. Individual treatment results and experience may vary.

[IMG: Caregiver ambassador Skip shows Margaret, a YESCARTA® (axicabtagene ciloleucel) patient ambassador, information on the computer.]

This testimonial is representative of the caregiver’s own experience. Individual treatment results and experience may vary.

[H2] Patient and caregiver perspectives

This testimonial is representative of patients’ and caregivers’ own experiences. Individual treatment results and experience may vary.

[IMG: Patient and caregiver monitoring side effects video thumbnail.]

Monitoring side effects
Learn more about what side effect monitoring was like for YESCARTA patients and caregivers
Play Video
play_arrow

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

[H3] Certified treatment centers

In order to provide YESCARTA, cancer treatment centers must first be certified. Certified treatment centers have specifically-trained medical staff, strict treatment protocols, and safety measures in place
for CAR T-cell therapy. These centers are often first to use best care practices learned through research.
Certified treatment centers are sometimes known as authorized treatment centers, or certified healthcare facilities.

Back to Top
expand_less

[H4] You are now leaving YESCARTA.com

The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving YESCARTA.com

You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3] Treatment center locator tool
There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA.
You can use the locator tool to find and learn about nearby treatment centers and their teams.
Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more.

Traveling From

Typical driving times around your location

1 hour
2 hours

Copy link
Print information

Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options.

[H3]
Cytokine Release Syndrome (CRS)

SY-toh-kine reh-LEES SIN-drome

CRS happens when your immune system becomes overactive.
After infusion, when the modified T cells recognize and kill cancer cells, they may release proteins called cytokines.

A buildup of cytokines can lead to symptoms including:
fever
chills
rapid heart rate
low blood pressure
low blood oxygen level

CRS can last for about a week and typically occurs in the first few days after infusion, when you are staying at the treatment center under the care of the treatment team.

[H3] Neurotoxicity
NOOR-oh-tok-SIH-sih-tee

Neurotoxicity is a side effect that happens when there is damage to the brain and spinal cord.
Neurotoxicity can cause symptoms like:
changes in the way the brain functions
seizures
changes in level of consciousness
difficulty with speech
tremors
confusion
Symptoms of neurotoxicity can last for 2–3 weeks and typically begin 4–5 days after YESCARTA infusion.

Approved Uses

YESCARTA is a prescription medicine used to treat two types of non-Hodgkin
lymphoma ...

Important Safety Information

What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that
are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma:

large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.

follicular lymphoma when at least two kinds of treatment have failed to control your cancer.

YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA. Your health
15000 chars
SUB-PAGE (https://yescarta.com/support-and-resources/) Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site
[H1]
Support and resources

[IMG: Patient support treatment team.]

On this page
Is YESCARTA covered by insurance?
Who can help me find information on resources and support?
Where else can I find support?
YESCARTA video library
Downloadable resources

[H2] Is YESCARTA covered by insurance?
Many insurance plans provide coverage for treatment.
You can talk to your healthcare team to discuss all the costs associated with YESCARTA, including out-of-pocket costs?.

How do I find out if my insurance covers YESCARTA?
chevron_right

If you don't have insurance, talk to your healthcare team about options available to you. There are other organizations that may be able to provide support if you are prescribed YESCARTA.

[H2] Who can help me find information on resources and support?

You don't have to figure everything out by yourself. Your treatment team is the best resource for support throughout treatment.
Our knowledgeable team at Kite is also dedicated to helping answer your questions about the treatment process.
You can call them at:

1-844-454-KITE [5483]

Monday–Friday
8 am–9 pm ET or 5 am–6 pm PT

[IMG: Individual talking to Kite Team on the phone.]

[H2] Where else can I find support?

Many organizations offer help throughout the process. The lists below are a starting point for finding organizations that may offer assistance programs. This is not an exhaustive list of support programs. You
can ask your treatment team about other support that might be available.

Resources may include referrals to independent third-party nonprofit patient assistance programs. These programs are not operated or controlled by Kite, and Kite does not endorse any program or third-party
organization. Nonprofit patient assistance program eligibility requirements may vary and are established solely by each independent organization. Kite makes no guarantee with respect to reimbursement or copay
assistance for any item or service.

Financial support
chevron_right

Travel and lodging support
chevron_right

Day-to-day support
chevron_right

Mental health, emotional support, and peer groups
chevron_right

Physical wellness support
chevron_right

Educational support
chevron_right

“There are things that you absolutely won't be able to do for yourself. When I needed something, I asked my caregiver, treatment team, friends, and neighbors. Don't be afraid—you'll be surprised how many people want to help.”

MargaretYESCARTA Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: Margaret YESCARTA® (axicabtagene ciloleucel) patient ambassador baking with caregiver Skip.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

There are also additional resources available just for caregivers. You can find links on the Caregiver support page.

[H2] YESCARTA video library
Patient and caregiver perspectives:
These testimonials are representative of patients’ and caregivers' own experiences. Individual treatment results and experience may vary.

[IMG: Patient CAR T infusion video thumbnail.]

What to know about CAR T
Learn about what was important to other patients and caregivers
Play Video
play_arrow

[IMG: Patient and caregiver treatment experience video thumbnail.]

The treatment process

Listen to patients and caregivers talk about their experience with YESCARTA treatment

Play Video
play_arrow

[IMG: A patient after YESCARTA® (axicabtagene ciloleucel) treatment video thumbnail.]

After treatment
Listen to patients and caregivers talk about recovery and life after YESCARTA treatment
Play Video
play_arrow

[IMG: Patient and caregiver monitoring side effects video thumbnail.]

Monitoring side effects
Learn more about what side effect monitoring was like for YESCARTA patients and caregivers
Play Video
play_arrow

[IMG: Caregiver care video thumbnail.]

Caregiver well-being
Caregivers talk about the importance of caring for themselves during YESCARTA treatment
Play Video
play_arrow

Learn about YESCARTA and the YESCARTA treatment process. These animations may help you explain YESCARTA and the YESCARTA treatment process to family and friends.

[IMG: Video thumbnail showing T cells and how CAR T works.]

What is CAR T-cell therapy?
Play Video
play_arrow

[IMG: YESCARTA® (axicabtagene ciloleucel) treatment process video thumbnail.]

What is the treatment process?
Play Video
play_arrow

[H2] Downloadable resources

YESCARTA Patient Wallet Card
chevron_right
YESCARTA Treatment Overview Book: English
chevron_right

YESCARTA Treatment Overview Book: Español
chevron_right

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

Back to Top
expand_less

[H4] You are now leaving YESCARTA.com

The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving YESCARTA.com

You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3] Treatment center locator tool
There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA.
You can use the locator tool to find and learn about nearby treatment centers and their teams.
Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more.

Traveling From

Typical driving times around your location

1 hour
2 hours

Copy link
Print information

Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options.

[H3] Out-of-pocket costs

There are out-of-pocket costs involved in the CAR T treatment process. ‘Out-of-pocket’ is any cost a patient has that is not covered by a health insurance plan. Examples include deductibles, co-payments for covered services, and costs for services that are not covered.

[H3] How do I find out if my insurance covers YESCARTA?

[IMG: Individual calling insurance provider for coverage information.]

If you're considering YESCARTA, your treatment team will look into your insurance coverage as part of the CAR T consultation process. They will work with your insurance provider to determine
what your coverage will be. They can also answer any questions you may have.

You may need to provide the following information in order to review your insurance coverage:
Your oncologist's name and phone number
The name of your treatment center and location
Your insurance member ID #
Other information about your plan, which can be found on your insurance card

[H3] Financial support

[H4] American Cancer Society

Patient Programs and Services

for help during and after cancer treatment

[H4]
Bone Marrow & Cancer Foundation

Financial Assistance Programs

financial assistance for patients and their families

[H4] BMT InfoNet

Patient Assistance Fund

helps with living expenses during treatment

[H4] CancerCare

Financial & Co-Payment Assistance

helps with treatment-related costs and finding additional resources

[H4] Cancer Support Community

Helpline

financial navigation, and treatment lodging and transportation resources, and other services

[H4] Family Reach Foundation

Get Help

financial assistance, tips, and resource navigation

[H4] Leukemia & Lymphoma Society

Financial Support

a list of financial assistance programs

[H4] Lymphoma Research Foundation

Helpline

phone or email service for financial assistance resources and other information

Patient Aid Grant

limited financial assistance to patients who are underinsured or struggle to pay for medical expenses

[H4] National Cancer Institute

Managing Costs and Medical Information

[H4] Patient Advocate Foundation

Patient Advocate Foundation

a selection of services that address financial and other obstacles to accessing healthcare

The organizations listed above are independent from Kite and Gilead, and this list is subject to change. This information is provided as a resource for patients and is not an endorsement or guarantee of
assistance.

[H3] Travel and lodging support

[H4]
Air Care Alliance

Patient and Medical Transport

organizes flights to help patients access distant medical care

[H4] American Cancer Society

Hope Lodge

home-like lodging environments for patients undergoing treatment

Patient Programs and Services

programs providing financial assistance, travel, lodging support, and more

Road to Recovery

transportation to and from treatment

[H4] BMT InfoNet

Patient Assistance Fund

helps with living expenses during treatment

[H4] Cancer Support Community

Helpline

treatment lodging and transportation resources, financial navigation, and other services

[H4] Corporate Angel Network

Corporate Angel Network

arranges free air travel for cancer patients on corporate planes

[H4] Footprints in the Sky

Footprints in the Sky

arranges free air travel for patients on charter and corporate planes

[H4] Grace On Wings

Grace On Wings

provides charity air ambulance services

[H4] Healthcare Hospitality Network

Need medical lodging?

a tool to search for a place to stay near your treatment center

[H4] Joe’s House

Joe’s House

helps patients find affordable places to stay when traveling for medical treatment

[H4] Leukemia & Lymphoma Society

Financial Support

a list of financial assistance programs, including lodging, transportation, and other non-medical expenses

[H4] Mercy Medical Angels

Mercy Medical Angels

assists with the cost of ground and air travel for patients needing to access medical care

[H3] Day-to-day support

[H4]
American Cancer Society

Patient Programs and Services

Road to Recovery program provides rides to patients to get to their cancer treatment

[H4] CancerCare

Resource Navigation
navigators and oncology social workers help connect patients and caregivers to resources

Pet Assistance and Wellness Program

assists with keeping a cat or dog at home while going through cancer treatment

[H4] Cancer Support Community

Helpline

treatment lodging and transportation resources, financial navigation, and other services

[H4] Leukemia & Lymphoma Society

Meals at Your Door

meal delivery service

One-On-One Nutrition Consultations

with registered dieticians

[H3] Mental health, emotional support, and peer groups

[H4] BMT InfoNet

Coping with Stress During CAR T-cell Therapy

Caring Connections Program

talk to a patient or caregiver who has been through CAR T treatment

[H4] Cancer.net

Counseling

information about counseling and finding a counselor

Resources for LGBTQ+ People

Support Groups

information about support groups and how to find one

[H4] CancerCare

Support Groups

led by professional oncology social workers

Counseling

Young Adults

information, resources, and support for young adults affected by cancer

Older Adults

information, resources, and support to help older people cope with cancer

[H4]
Cancer Support Community

MyLifeLine

online community of patients, survivors, and caregivers

[H4] Leukemia & Lymphoma Society

Support Groups

search for support groups for anyone affected by blood cancer

Patti Robinson Kaufmann First Connection® Program

peer-to-peer support

[H4] Lymphoma Research Foundation

Lymphoma Support Network

a one-to-one peer support program

[H4] Patient Empowerment Network

Non-Hodgkin’s Lymphoma Friends

a peer support community for patients living with Non-Hodgkin’s Lymphoma, and their caregivers

[H3] Physical wellness support

[H4]
American Cancer Society

Coping and Living Well During Cancer Treatment

[H4] American Institute for Cancer Research

Tips throughout treatment

[H4]
CancerCare

Information about nutrition

Information about sleep

[H4]
Cancer Support Community

Exercise for wellness gui
15000 chars
SUB-PAGE (https://yescarta.com/clinical-trial-results/) YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site
[H1]
YESCARTA results

[IMG: Medical professionals studying results.]

On this page
How has YESCARTA been studied?
For LBCL patients whose cancer returned after their first treatment
What are the results from the other YESCARTA clinical trials?
Where can I learn more about the possible side effects of YESCARTA?

[H2] How has YESCARTA been studied?

YESCARTA has been studied across multiple clinical trials to look at how well it works, how safe it is, and who it might help. The FDA has approved YESCARTA for multiple uses based on the outcomes of these
trials.

[H2] For LBCL patients whose cancer returned after their first treatment: YESCARTA showed improved results compared to standard therapy.

Trial in LBCL (2nd line)
A clinical trial looked at adult patients with Large B-Cell Lymphoma who have tried one previous treatment that didn’t work or the cancer
came back within 12 months (also called 2nd line). The goal of this trial was to see if YESCARTA improved the clinical outcome for patients when compared to
standard therapy?. Standard therapy in this trial included chemoimmunotherapy,
high-dose therapy, and autologous stem cell transplant, depending on how the cancer responded to treatment.

Trial design
Results and highlights

[IMG: Purple circle icon with 2x text]

[IMG: First and only approved CAR T treatment in adult 2L LBCL]

[H2] What are the results from the other YESCARTA clinical trials?
Other key clinical trials looked at how YESCARTA works for adult patients with different types of relapsed/refractory (R/R) cancer and treatment histories.
Click below to see the clinical trial results for the cancer type you want to learn more about:

Talk to your healthcare team if you want to learn more about the clinical trial results for your type of blood cancer.
There are ongoing clinical trials to see if YESCARTA can be used safely and effectively in other situations.

“My post-CAR T scan showed I was officially in remission! It was a day I had hoped for but feared wouldn’t come. A couple of weeks after that I felt the weight lift from my shoulders.”

LayraYESCARTA Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: Layra YESCARTA® (axicabtagene ciloleucel) patient ambassador looking in mirror.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[H2] Where can I learn more about the possible side effects of YESCARTA?
Patients in YESCARTA clinical trials also experienced side effects. You can learn more about these side effects by:
reading the Important Safety Information.
visiting the Managing side effects page to learn more about how to look out for side effects.
talking to your treatment team.

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

Back to Top
expand_less

[H4] You are now leaving YESCARTA.com

The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving YESCARTA.com

You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3] Treatment center locator tool
There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA.
You can use the locator tool to find and learn about nearby treatment centers and their teams.
Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more.

Traveling From

Typical driving times around your location

1 hour
2 hours

Copy link
Print information

Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options.

[H3] Standard therapy

A standard therapy is a treatment that is accepted by doctors as a suitable and widely used treatment for a certain type of disease. Also called “standard of care.”

[H3] Overall survival
Overall survival (OS) is the length of time that patients remain alive after starting a treatment.
Researchers and doctors use overall survival data to help determine how well a treatment works.

[H3] Event-free survival
In clinical trials, an event is when a patient’s cancer comes back, gets worse, or experiences any other complications or worsening of symptoms.
Event free means a patient has not experienced an event.
Event-Free Survival (EFS) measures the length of time after treatment that patients go without having an event. Researchers and doctors use event-free survival data to help determine how well a treatment works.

Approved Uses

YESCARTA is a prescription medicine used to treat two types of non-Hodgkin
lymphoma ...

Important Safety Information

What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that
are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read
7062 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
18Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 2 0
/managing-side-effects/ 8 0
/support-and-resources/ 5 0
/clinical-trial-results/ 3 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/managing-side-effects/ — no schema detected (entity gap)
/support-and-resources/ — no schema detected (entity gap)
/clinical-trial-results/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: YESCARTA (Kite/Gilead) (yescarta.com)

https://yescarta.com 📍 Industry: Medical Devices, Pharma & Biotech
18 BS / 100

A model of low-BS pharmaceutical communication that prioritizes regulatory compliance and clinical specificity over marketing hyperbole. The site delivers a high volume of ‘inconvenient’ safety data alongside its efficacy claims, which serves as a significant bullshit-reducing signal. Only the lack of technical schema and direct journal citations prevent a perfect score.

Info Density Power-words vs. Substance ratio.
4
13% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
5
25% BS
Commodity Fingerprint Detection of industry clichés/templates.
4
27% BS
Identity & Authority Expert verifiability & Schema depth.
5
33% BS

Implement MedicalTherapy and Organization schema to provide machine-readable authority signals and link to Kite/Gilead sameAs profiles. Add a ‘References’ section on the Clinical Results page with direct outbound links to the published ZUMA trial results in peer-reviewed journals. Reduce repetition of the ‘one-time infusion’ value prop across the ‘Support’ page to focus more on logistical evidence. Explicitly link to the FDA approval letter to move from ‘Trust Theatre’ to ‘Verified Proof.’

The site is perfectly aligned with the Pharma and Biotech industry, specifically the CAR T-cell therapy sector. The presence of mandatory Important Safety Information (ISI) and specific medical indications for LBCL and FL confirms high industry relevance.

“The score is primarily driven by technical authority gaps (missing schema) and the inherent template-like nature of pharma websites. The Information Density and Semantic Coherence pillars scored nearly perfectly due to the high volume of specific, qualified medical data. Total BS Score: 18.”

Verified Analysis Date: June 20, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result